103 related articles for article (PubMed ID: 9399737)
1. Effects of hormone therapy on inflammatory cell adhesion molecules in postmenopausal healthy women.
Koh KK; Bui MN; Mincemoyer R; Cannon RO
Am J Cardiol; 1997 Dec; 80(11):1505-7. PubMed ID: 9399737
[TBL] [Abstract][Full Text] [Related]
2. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.
Yeboah J; Klein K; Brosnihan B; Reboussin D; Herrington DM
Menopause; 2008; 15(6):1060-4. PubMed ID: 18521047
[TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy does not affect plasma homocysteine in postmenopausal women with coronary artery disease. Free tissue factor pathway inhibitor antigen, a circulating anticoagulant, is related to plasma homocysteine.
Os I; Os A; Sandset PM; Bølling S; Seljeflot I; Djurovic S; Westheim A
Cardiology; 2002; 98(1-2):6-12. PubMed ID: 12373040
[TBL] [Abstract][Full Text] [Related]
4. Effect of short-term estrogen with and without progesterone therapy on circulating markers of endothelial activation and injury in postmenopausal women with unstable angina pectoris.
Chou ET; Schulman SP; Thiemann DR; Sohn RH; Bellantoni MF; Rade JJ
Am J Cardiol; 2003 May; 91(10):1240-2. PubMed ID: 12745110
[No Abstract] [Full Text] [Related]
5. Inflammation, coronary artery disease, and hormones.
Lobo RA
Menopause; 2008; 15(6):1036-8. PubMed ID: 18779754
[No Abstract] [Full Text] [Related]
6. Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management.
Zanger D; Yang BK; Ardans J; Waclawiw MA; Csako G; Wahl LM; Cannon RO
J Am Coll Cardiol; 2000 Nov; 36(6):1797-802. PubMed ID: 11092646
[TBL] [Abstract][Full Text] [Related]
7. Effects of transdermal hormone replacement therapy on levels of soluble P- and E-selectin in postmenopausal healthy women.
Farzati A; Esposito K; Colacurci N; Fornaro F; Chiantera V; Farzati B
Fertil Steril; 2002 Mar; 77(3):476-80. PubMed ID: 11872198
[TBL] [Abstract][Full Text] [Related]
8. Effect of medroxyprogesterone acetate on vascular inflammatory markers in postmenopausal women receiving estrogen.
Wakatsuki A; Okatani Y; Ikenoue N; Fukaya T
Circulation; 2002 Mar; 105(12):1436-9. PubMed ID: 11914251
[TBL] [Abstract][Full Text] [Related]
9. Association of circulating cellular adhesion molecules with menopausal status and hormone replacement therapy. Time-dependent change in transdermal, but not oral estrogen users.
Oger E; Alhenc-Gelas M; Plu-Bureau G; Mennen L; Cambillau M; Guize L; Pujol Y; Scarabin P
Thromb Res; 2001 Jan; 101(2):35-43. PubMed ID: 11342204
[TBL] [Abstract][Full Text] [Related]
10. Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response.
Silvestri A; Gebara O; Vitale C; Wajngarten M; Leonardo F; Ramires JA; Fini M; Mercuro G; Rosano GM
Circulation; 2003 Jul; 107(25):3165-9. PubMed ID: 12796135
[TBL] [Abstract][Full Text] [Related]
11. Effect of hormonal replacement therapy on C-reactive protein and cell-adhesion molecules in postmenopausal women.
Lamon-Fava S; Posfai B; Schaefer EJ
Am J Cardiol; 2003 Jan; 91(2):252-4. PubMed ID: 12521647
[No Abstract] [Full Text] [Related]
12. Effects of oral and transdermal estrogen therapies on circulating cytokines and chemokines in postmenopausal women with hysterectomy.
Yasui T; Saijo A; Uemura H; Matsuzaki T; Tsuchiya N; Yuzurihara M; Kase Y; Irahara M
Eur J Endocrinol; 2009 Aug; 161(2):267-73. PubMed ID: 19451213
[TBL] [Abstract][Full Text] [Related]
13. Effect of etanercept on serum levels of soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor in patients with rheumatoid arthritis.
Klimiuk PA; Sierakowski S; Domyslawska I; Chwiecko J
Scand J Rheumatol; 2009; 38(6):439-44. PubMed ID: 19922018
[TBL] [Abstract][Full Text] [Related]
14. Effects of oral soy protein on markers of inflammation in postmenopausal women with mild hypercholesterolemia.
Blum A; Lang N; Peleg A; Vigder F; Israeli P; Gumanovsky M; Lupovitz S; Elgazi A; Ben-Ami M
Am Heart J; 2003 Feb; 145(2):e7. PubMed ID: 12595862
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of tibolone on circulating levels of vascular cell adhesion molecules and E-selectin in postmenopausal women.
Cicinelli E; Ranieri G; Maffei S; Colafiglio G; Ria R; Bellavia M; Schonauer MM
Fertil Steril; 2006 Oct; 86(4):899-904. PubMed ID: 16963035
[TBL] [Abstract][Full Text] [Related]
16. Effects of transdermal and oral postmenopausal hormone therapy on vascular function: a randomized, placebo-controlled study in healthy postmenopausal women.
Hemelaar M; van der Mooren MJ; van Baal WM; Schalkwijk CG; Kenemans P; Stehouwer CD
Menopause; 2005; 12(5):526-35. PubMed ID: 16145306
[TBL] [Abstract][Full Text] [Related]
17. Short-term hormone replacement therapy: reduced plasma levels of soluble adhesion molecules.
Van Baal WM; Emeis JJ; Kenemans P; Kessel H; Peters-Muller ER; Schalkwijk CG; van der Mooren MJ; Stehouwer CD
Eur J Clin Invest; 1999 Nov; 29(11):913-21. PubMed ID: 10583435
[TBL] [Abstract][Full Text] [Related]
18. Beneficial influence of postmenopausal estrogen therapy on serum adhesion molecules is independent of the route and dose of administration.
Rajtar-Ciosek A; Huras H; Krzysiek J; Reroń A; Wilczak M; Jach R
Neuro Endocrinol Lett; 2011; 32(3):340-4. PubMed ID: 21670727
[TBL] [Abstract][Full Text] [Related]
19. Vascular effects of estrogen in type II diabetic postmenopausal women.
Koh KK; Kang MH; Jin DK; Lee SK; Ahn JY; Hwang HY; Yang SH; Kim DS; Ahn TH; Shin EK
J Am Coll Cardiol; 2001 Nov; 38(5):1409-15. PubMed ID: 11691516
[TBL] [Abstract][Full Text] [Related]
20. Consumption of isoflavone-rich soy protein does not alter homocysteine or markers of inflammation in postmenopausal women.
Greany KA; Nettleton JA; Wangen KE; Thomas W; Kurzer MS
Eur J Clin Nutr; 2008 Dec; 62(12):1419-25. PubMed ID: 17805230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
